Hormone Replacement Therapy May Improve Survival for Women with Ovarian Cancer
The randomized, controlled Adjuvant Hormone Therapy trial was launched in 1990 to assess the effects of estrogen-alone hormone replacement therapy in women treated for epithelial ovarian cancer.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/1014731/syndication
- Syndication ID: 3669
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Friday, October 23, 2015 at 01:00 AM
- Date Syndication Updated: Monday, August 05, 2019 at 07:39 PM
hormone replacement therapy
institute for cancer research
women’s health initiative
womens health initiative
Embed Code Snippet
To get the embed code snippet please Login.